Kaplan-Meier estimates of duration of response, progression-free survival, and overall survival of patients with HCL at different time points (intent-to-treat population)
| . | n . | 6 months . | 12 months . | 24 months . |
|---|---|---|---|---|
| DOR, % (95% CI) | 49 | 100.0 (100.0-100.0) | 97.7 (84.6-99.7) | 97.7 (84.6-99.7) |
| PFS, % (95% CI) | 55 | 96.4 (86.2-99.1) | 96.4 (86.2-99.1) | 94.4 (83.5-98.1) |
| OS, % (95% CI) | 55 | 96.4 (86.2-99.1) | 96.4 (86.2-99.1) | 94.5 (83.9-98.2) |
| . | n . | 6 months . | 12 months . | 24 months . |
|---|---|---|---|---|
| DOR, % (95% CI) | 49 | 100.0 (100.0-100.0) | 97.7 (84.6-99.7) | 97.7 (84.6-99.7) |
| PFS, % (95% CI) | 55 | 96.4 (86.2-99.1) | 96.4 (86.2-99.1) | 94.4 (83.5-98.1) |
| OS, % (95% CI) | 55 | 96.4 (86.2-99.1) | 96.4 (86.2-99.1) | 94.5 (83.9-98.2) |